Compare CDNA & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | ODC |
|---|---|---|
| Founded | 1998 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Miscellaneous manufacturing industries |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 995.6M |
| IPO Year | 2007 | 1994 |
| Metric | CDNA | ODC |
|---|---|---|
| Price | $17.06 | $64.19 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $27.33 | N/A |
| AVG Volume (30 Days) | ★ 539.5K | 60.0K |
| Earning Date | 05-13-2026 | 06-19-2026 |
| Dividend Yield | N/A | ★ 1.25% |
| EPS Growth | N/A | ★ 50.45 |
| EPS | N/A | ★ 1.69 |
| Revenue | $48,324,000.00 | ★ $485,572,000.00 |
| Revenue This Year | $15.37 | N/A |
| Revenue Next Year | $11.23 | N/A |
| P/E Ratio | ★ N/A | $38.73 |
| Revenue Growth | ★ 18.93 | 10.97 |
| 52 Week Low | $10.96 | $41.37 |
| 52 Week High | $21.49 | $70.01 |
| Indicator | CDNA | ODC |
|---|---|---|
| Relative Strength Index (RSI) | 37.34 | 49.03 |
| Support Level | $16.74 | $55.97 |
| Resistance Level | $17.09 | $66.83 |
| Average True Range (ATR) | 0.83 | 2.61 |
| MACD | -0.21 | -0.61 |
| Stochastic Oscillator | 23.77 | 26.02 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.